MedVi vs Luvo Health: Semaglutide vs Tirzepatide Options Compared
MedVi vs Luvo Health: If you want the quickest answer, MedVi is explicit about a promotional semaglutide program starting at $179 for the first month with no clinic visits and 24/7 certified medical support, while Luvo Health presents clinician-reviewed programs that include tirzepatide and semaglutide options but does not publish verified starting pricing or full terms on the captured page. Early verdict: choose MedVi for a clear promotional price and a fully remote semaglutide program; choose Luvo Health only if you need confirmed access to tirzepatide and will verify eligibility, cost, and state availability first.
See MedVi pricing and program details
How they differ in price and transparency
MedVi provides a concrete promotional price: compounded semaglutide starting at $179 for the first month including fast, free shipping, with standalone months at $299 and a three-month plan at $649. Luvo Health shows tiered month labels and ongoing support language but the captured landing page did not publish verified starting pricing, renewal terms, or state availability. That makes MedVi more transparent on initial cost in the captured evidence.
Medication options and prescribing approach
MedVi focuses on clinically dosed compounded semaglutide only, per the captured evidence. Luvo Health lists tirzepatide injection plus semaglutide injection and tablets, indicating multiple medication formats may be available, but pricing and eligibility details were not verified on the captured page. Both providers operate under clinician review and only offer treatment when a licensed clinician determines it is medically appropriate.
Process and support: remote care versus live clinician review
MedVi emphasizes a simple online intake with no clinic visits needed and 24/7 certified medical support. The MedVi program states a licensed clinician reviews each case and clinicians retain prescribing discretion. Luvo Health describes clinician-reviewed online weight management with dose adjustments based on clinical response and ongoing support, but the captured evidence did not confirm exact onboarding steps or whether clinic visits are required. If continuous around-the-clock support is a priority, the captured evidence supports that MedVi advertises 24/7 support.
Review Luvo Health program options
Regulatory and compounded medication notes
Both sources clearly note that compounded medications are prepared by licensed pharmacies and are not reviewed or approved by the FDA. MedVi adds that compounded GLP-1s are produced in FDA-regulated facilities but are not FDA-approved, and that the decision to use compounded drugs is guided by licensed providers and subject to clinician review. Luvo Health also states that compounded medications are not reviewed by the FDA on the captured page.
Outcomes, guarantees, and what the evidence shows
MedVi includes self-reported patient data and notes typical MedVi patient weight change reported as 1-2 lbs per week after 4 weeks under certain conditions, while also cautioning results vary and that medication prescriptions are at clinician discretion. MedVi does not publish a formal guarantee beyond marketing statements captured. Luvo Health did not include captured outcome claims or guarantees on the landing page evidence provided.
| Criteria | MedVi | Luvo Health |
|---|---|---|
| Starting price | Promotional first month $179; ongoing months from $299; three-month plan $649 | Not verified on captured page |
| Medications offered | Compounded semaglutide only | Tirzepatide injection, semaglutide injection, semaglutide tablets listed |
| Onboarding process | Online intake, no clinic visits; clinician review | Clinician-reviewed online programs; details not verified |
| Support | 24/7 certified medical support (advertised) | Ongoing support and dose changes (described) |
| Regulatory note | Compounded meds not FDA-approved; produced in FDA-regulated facilities | Compounded meds not FDA-approved; not reviewed by FDA |
Check Luvo Health eligibility and state availability
Practical differences that matter
If immediate price clarity and a fully remote semaglutide-only workflow are priorities, the captured evidence supports MedVi as the clearer option due to a published promotional price and an explicit no-clinic process. If access to tirzepatide or tablet options is essential, Luvo Health lists those medications on the captured page but requires prospective users to confirm pricing, eligibility, pharmacy, and state coverage because those details were not published or verified on the captured landing page.
Choose Provider if…
Choose MedVi if you want a clearly published promotional semaglutide program starting at $179 for month one, prefer no clinic visits, and value advertised 24/7 certified medical support. Choose Luvo Health if you need potential access to tirzepatide or multiple formulation options and will confirm cost, renewal terms, and state availability before enrolling.